Why do some people who consume a few glasses of alcohol a day develop advanced liver disease while others who drink the same ...

Scientists at Michigan Medicine have made a significant breakthrough in treating nonalcoholic fatty liver disease (NAFLD), a ...

In the first half of 2025, Ozempic developer Novo Nordisk in Bagsværd, Denmark, expects results from a second phase III trial ...

A high-resolution spatial map of the human hypothalamus makes it possible to identify specific cells, determine their exact ...

SGLT-2 inhibitors vs DPP-4 inhibitors were associated with a reduced risk for liver cirrhosis among patients with type 2 diabetes.

American host and television producer Oprah Winfrey recently shared her initial experience of taking the weight loss drug GLP ...